アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
Erythromycin conjugated to BSA/BTG.
Our Abpromise guarantee covers the use of ab123983 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Competitive ELISA||Use a concentration of 10 µg/ml. 10ng/ml Erythromycin produces 87% inhibition in a competitive ELISA employing ab123983.|
|Purification||Use a concentration of 10 µg/ml. ab123983 is suitable for the development of immunoaffinity purification columns.|
|ICC/IF||Use at an assay dependent concentration.|
ab123983 has not yet been referenced specifically in any publications.